Found 35 matching trials
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) PHASE3 The purpose of the study is to evaluate efficacy of riliprubart compared to...
Show More Location
Alabama Neurology Associates- Site Number : 8400019
Learn More & Join Trial
Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing N/A CIDP and MMN are part of a group of chronic inflammatory conditions that af...
Show More Location
The Walton Centre NHS Foundation Trust
Learn More & Join Trial
Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) NA Participants will be requested to deliver non-invasive vagus nerve stimulat...
Show More Location
Children's Healthcare of Atlanta, Center for Advanced Pediatrics
Learn More & Join Trial
Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy N/A This study aims analyze the transcriptome to identify predictive biomarkers...
Show More Location
CHU Bordeaux, service de Neurologie
Learn More & Join Trial
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) PHASE2 This is a randomized controlled study evaluating safety and efficacy of rep...
Show More Location
Department of Neurology, University of Ulm
Learn More & Join Trial
A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) N/A The main aim of this study is to evaluate the rates of adverse events of sp...
Show More Location
RTI Health Solutions
Learn More & Join Trial
Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP N/A The goal of this observational study is to learn about chronic inflammatory...
Show More Learn More & Join Trial
IVIG vs SCIG in CIDP PHASE1 Current dosing practices for immunoglobulin G (IgG) may be inadequate in ex...
Show More Location
Rutgers, The State University of New Jersey Clinical Research Center
Learn More & Join Trial
Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC) PHASE4 SIDEC - (Subcutaneous Immunoglobulin in De-novo CIDP) ia a study designed a...
Show More Location
Department of Neurology, Aalborg University Hospital
Learn More & Join Trial
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) PHASE3 The main aim of this study is to evaluate the pharmacokinetic (PK) comparab...
Show More Location
HonorHealth Neurology
Learn More & Join Trial